Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
AverageAstrana is a leading physician-centric, technology-powered, risk-bearing healthcare company. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver accessible, high-quality care to patients in a cost-effective manner.
In the company’s own words · 10-K filed Mar 12, 2026 · SEC EDGAR
Business segments
Q1 2026 · $965.1MThe company’s own SEC segment disclosure.
- Health Care Capitation$892.9M93%
- Health Care Patient Service$37.8M4%
- Management Service$15.7M2%
- Health Care Other$12.5M1%
- Product And Service Other$6.2M1%
Astrana Health, Inc. (ASTH) reported revenue of $965M in Q1 2026 (quarter ended March 31, 2026), up 56% from the same quarter a year earlier. That came with a gross margin of 11% and net income of $14M (1.5% of revenue). For the full year FY2025, revenue was $3.18B (+56% year on year) and net income $22M. Its largest product in 2026-Q1 was Health Care Capitation at $893M, 93% of the disclosed total, just ahead of Health Care Patient Service at 3.9%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.